Le Lézard
Classified in: Health
Subjects: MAV, SVY, FVT, CFG

Media Advisory - Member of Parliament Stephen Fuhr to highlight spinal cord injury research at the University of British Columbia - Okanagan Campus


KELOWNA, BC, Feb. 16, 2018 /CNW/ - Member of Parliament for Kelowna?Lake Country, Stephen Fuhr, on behalf of the Honourable Ginette Petitpas Taylor, federal Minister of Health, will visit the University of British Columbia's Okanagan campus to tour a lab, meet a research team, and highlight an investment in spinal cord injury research.

Media are invited to join the demonstration and Q&A with the researcher and MP Fuhr.   

Date:   
February 19, 2018                   

Time:             
10:00 a.m.  PST

Location:      
Hangar Fitness and Wellness Centre
3211 Athletics Court
University of British Columbia ? Okanagan Campus
Kelowna, British Columbia
V1V 1V7       

 

SOURCE Canadian Institutes of Health Research


These press releases may also interest you

at 03:11
Dr. Denis Mukwege, Congolese Gynecological Surgeon and Human Rights Activist, Awarded the 2024 Aurora Prize
The eighth Aurora Prize for Awakening Humanity was awarded Thursday evening to Dr. Denis Mukwege, a world-renown gynecological surgeon and human rights activist from the Democratic Republic of the Congo (DRC). Dr. Mukwege is the president of Panzi...

at 03:05
The National Institute for Health and Care Excellence (NICE) Recommends Use of Exact Sciences' Oncotype DX® Test to Help Guide Chemotherapy Decisions for Node-positive Breast Cancer Patients
Exact Sciences, a leading provider of cancer screening and diagnostic tests, today announced that the UK's National Institute for Health and Care Excellence (NICE) has recommended the expanded use of the Oncotype DX Breast Recurrence Score® test to...

at 03:00
San Luis Obispo electrician answers 'Home or public EV charging, which is best?'
Charging an electric vehicle (EV) at home is certainly more convenient than using a public charging station, but what are the other benefits? Along with convenience, the...

at 02:15
Novavax Reports First Quarter 2024 Financial Results and Operational Highlights
Announces co-exclusive licensing agreement with Sanofi to co-commercialize COVID-19 vaccine, develop novel COVID-19-Influenza combination vaccines and develop multiple new vaccines utilizing Novavax's Matrix-MTM adjuvantThis agreement represents a...

at 02:05
Shionogi & Co., Ltd. and Maze Therapeutics, Inc. Announce Exclusive Worldwide License Agreement for MZE001, a Novel Therapeutic Candidate for the Treatment of Pompe Disease
Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter "Shionogi") and Maze Therapeutics, Inc. (Head Office: South San Francisco, California, USA; Chief Executive Officer: Jason Coloma, Ph.D.;...

at 02:00
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
Agreement provides individuals with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, from 2025 onwardsProvides Novavax with cash and an equity investment totalling approximately $1.2 billion...

More news about Health...


News published on and distributed by: